ReviewJournal of family medicine and primary care2022
P300, a tool for cognitive assessment in women with iron deficiency anemia: A systematic review.
Review in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Iron-deficiency anemia (IDA) is a common nutritional disorder and an important risk factor for the development of mild cognitive impairment that may progress to dementia, if untreated. The anemic status due to iron deficiency (ID) alters the electrogenesis in the central nervous system. P300 is a cognitive evoked potential (CEP) used as an objective tool to assess cognitive function. Mild cognitive impairment is indicated by prolonged P300 wave latency and reduced amplitude. IDA is highly prevalent among women particularly in the reproductive phase and data on cognitive assessment using P300 in them are sparse. This review aims to analyze the evidence from recent literature regarding the effect of IDA on evoked potentials like P300 in women. A systematic literature review was conducted and databases, like PubMed, Medline, Scopus, and Google Scholar, were searched for studies from the last 20 years. We selected research papers that compared P300 between anemic women and controls of the same age, and evaluated the effects of iron supplementation on P300 in anemic women. Based on the inclusion criteria, three studies were found. The studies demonstrated impaired P300 potentials in anemic women that improved following iron supplementation. Promoting screening of anemic women with P300 aids in the early detection of subclinical cognitive decline. Ensuring adequate iron treatment can prevent mild cognitive impairment from progressing to severe forms like dementia and other neuropsychological disorders. Further studies utilizing P300 as a cognitive tool need to be encouraged to establish definite conclusions regarding its efficacy in detecting cognitive dysfunctions in anemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.